Bon Natural Life Ltd., a leading bio-ingredient solutions provider, has announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a prominent wellness company in China. The agreement, valued at up to $16 million, spans 24 months and involves the marketing, sale, and distribution of Bon's natural prebiotic series products in the Chinese market. This collaboration is seen as a significant step forward in the gut health sector, featuring a cutting-edge "Prebiotic + Postbiotic" complex with the flagship active ingredient, super prebiotic stachyose. Bon anticipates this strategic partnership will accelerate its entry into China's rapidly growing gut health market, driving substantial growth opportunities for both companies.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。